Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$10.31
-0.54-4.98%
Last update: Nov 13, 11:44 AM
Comments
Loading...
Prothena Corp (PRTA) Stock Price, Quote, News & History
PRTANASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Prothena Corp (PRTA) stock?
You can purchase shares of Prothena Corp (NASDAQ:PRTA) through any online brokerage.
Who are Prothena Corp (PRTA) competitors?
Other companies in Prothena Corp’s space includes: KalVista Pharmaceuticals (NASDAQ:KALV), 4D Molecular Therapeutics (NASDAQ:FDMT), Monopar Therapeutics (NASDAQ:MNPR), ADC Therapeutics (NYSE:ADCT) and MapLight Therapeutics (NASDAQ:MPLT).
What is the forecast, or price target, for Prothena Corp (PRTA) stock?
Prothena Corp has a consensus price target of $38.00.
What is the current price for Prothena Corp (PRTA)?
The stock price for Prothena Corp (NASDAQ: PRTA) is $10.31 last updated November 13, 2025 at 11:44 AM EST.
Does Prothena Corp (PRTA) pay a dividend?
There are no upcoming dividends for Prothena Corp.
When is Prothena Corp (NASDAQ:PRTA) reporting earnings?
Prothena Corp’s Q3 earnings are confirmed for Thursday, November 6, 2025.
Is Prothena Corp (PRTA) going to split?
There is no upcoming split for Prothena Corp.
What sector and industry does Prothena Corp (PRTA) operate in?
Prothena Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
